Finance

Lists
LABS:TSE
Medipharm Labs Corp
0,070 CAD
0,00%
(0,00) 1D
13-окт., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LABS...
Open
0,07 CAD
High
0,07 CAD
Low
0,06 CAD
Mkt. cap
29,90 млн
Avg. vol.
97,26 миң
Volume
207,42 миң
52-wk high
0,10 CAD
52-wk low
0,06 CAD
EPS
-0,01 CAD
Beta
0,43
Shares outstanding
427,18 млн
No. of employees
127
Open
0,07 CAD
High
0,07 CAD
Low
0,06 CAD
Mkt. cap
29,90 млн
Avg. vol.
97,26 миң
Volume
207,42 миң
52-wk high
0,10 CAD
52-wk low
0,06 CAD
EPS
-0,01 CAD
Beta
0,43
Shares outstanding
427,18 млн
No. of employees
127
News stories
From web sources and news partners
About Medipharm Labs Corp
CEO-
Employees127
Founded2015
HeadquartersБарри, Онтарио, Канада
SectorPharmaceutical industry
Last report
2026-ж., 13-авг.
Fiscal period
Q2 2026
- / -
Revenue / Est. (CAD)
9,98 млн / 8,93 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
11,45 млн
11,06 млн
8,96 млн
9,98 млн
Cost of goods sold
8,90 млн
7,26 млн
5,65 млн
5,56 млн
Cost of revenue
8,90 млн
7,26 млн
5,65 млн
5,56 млн
Research and development expenses
47,00 миң
52,00 миң
24,00 миң
83,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,50 млн
4,40 млн
4,28 млн
3,93 млн
Operating expense
4,74 млн
4,77 млн
4,30 млн
4,35 млн
Total operating expenses
13,64 млн
12,03 млн
9,96 млн
9,90 млн
Operating income
-2,19 млн
-967,00 миң
-994,00 миң
82,00 миң
Other non operating income
-
-
-
-
EBT including unusual items
-2,14 млн
-1,97 млн
-867,00 миң
4,00 миң
EBT excluding unusual items
-2,14 млн
-965,00 миң
-867,00 миң
120,00 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
189,00 миң
358,00 миң
-2,00 миң
-110,00 миң
Net income
-2,14 млн
-1,97 млн
-867,00 миң
4,00 миң
Net profit margin
-18,71%
-17,79%
-9,67%
0,04%
Earnings per share
-
-
-
-
Interest and investment income
62,00 миң
58,00 миң
60,00 миң
50,00 миң
Interest expense
-16,00 миң
-19,00 миң
-15,00 миң
-12,00 миң
Net interest expenses
46,00 миң
39,00 миң
45,00 миң
38,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,78 млн
-580,00 миң
-621,00 миң
458,00 миң
Gain or loss from assets sale
181,00 миң
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору